switching from semaglutide to retatrutide for weight loss: Study shows 30% body weight loss switch from semaglutide to retatrutide

Bifidobacterium infantis - produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1

Mounjaro (tirzepatide) is a new, injectable medication indicated for use in patients with type 2 diabetes

8 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 9 Study Rationale The prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing in the U.S., accounting for over half of all cases of heart failure

GLP-1 GLP-1GIP/GLP-12 GLP-1GIP/GLP-1 GLP-1 GLP-1Glucagon-Like Peptide-1-1 : GLP-1 : GLP-1 : GLP-1 : GLP-1 GLP-1GLP-1 GLP-1 11112 1130 GIP/GLP-1 GIP/GLP-1GLP-1GIPGastric Inhibitory Polypeptide GIPGLP-12GIPGIP GIP GIP GIPGLP-1 2023GIP/GLP-1 SURPASS 4015 mg/HbA1c29.5 kg GLP-1HbA1c GLP-1 GLP-1GIP/GLP-10 GLP-12 GLP-11.271.361.55 13GLP-11.5GLP-1 GLP-1GIP/GLP-12 MazdutideGLP-12Mazdutide2HbA1c20HbA1c1.67%7.1% GIPGLP-13 Retatrutide12 mg/24HbA1c2%3617%Retatrutide481 mg8.74 mg17.18 mg22.812 mg24.21/4 GLP-1GIP Nauck MA, Quast DR, Wefers J, Pfeiffer AFH

The median follow up was 3.4 years after early trial cessation was recommended at a prespecified interim analysis